Pharmacy Benefits Management (PBM): The Complete Guide

What Is a PBM?

A Pharmacy Benefit Manager (PBM) is a third-party administrator of prescription drug programs for health plans, self-insured employers, Medicare Part D plans, and other payers. The three largest PBMs — Express Scripts (owned by Cigna), CVS Caremark, and OptumRx (owned by UnitedHealth Group) — together manage pharmacy benefits for more than 270 million Americans.

PBMs sit between employers (plan sponsors), pharmacies, and pharmaceutical manufacturers. In theory, they negotiate lower drug prices and manage pharmacy networks on behalf of plan sponsors. In practice, the relationship is far more complex — and often less favorable to plan sponsors than it appears on paper.

How PBMs Make Money

Understanding PBM economics is essential for any benefits professional negotiating or managing a PBM contract. PBMs earn revenue through multiple channels, not all of which are transparent:

1. Administrative Fees

The visible and straightforward revenue source: per-claim or per-member-per-month (PMPM) administrative fees paid by the plan sponsor. These are explicitly disclosed in contracts and are often used as the primary focus during PBM negotiations — sometimes to distract from more opaque revenue streams.

2. Manufacturer Rebates

PBMs negotiate rebates from pharmaceutical manufacturers in exchange for favorable formulary placement. These rebates can be substantial — often hundreds of millions of dollars annually for large PBMs. The critical question is what percentage of rebates flows back to the plan sponsor. Traditional "rebate retention" models allow PBMs to keep a portion; transparent "pass-through" models guarantee 100% of rebates to the client. Knowing the difference — and negotiating accordingly — is one of the most impactful skills the CPBS certification teaches.

3. Spread Pricing

Spread pricing is among the most controversial PBM practices. In a spread pricing model, the PBM reimburses a pharmacy a certain amount for a drug, then charges the plan sponsor a higher amount — pocketing the difference (the "spread"). In a 2018 Ohio Medicaid audit, spread pricing was found to cost the state $224 million in a single year. Transparent PBM models eliminate spread pricing by passing through the exact pharmacy reimbursement rate to the plan sponsor.

4. Pharmacy Network Discounts

PBMs negotiate discounts with pharmacies in their network. The published discount (e.g., AWP-20%) represents what the plan sponsor sees. The actual rate the PBM negotiated may be more favorable, with the PBM retaining the difference — another form of spread.

5. Specialty Drug Revenue

PBMs often own specialty pharmacies (CVS Caremark owns CVS Specialty; OptumRx owns Optum Specialty Pharmacy). They can steer specialty drug prescriptions to their affiliated pharmacies — a practice that may or may not be in the plan sponsor's best interest. Understanding this conflict of interest is essential for managing specialty drug spend.

Key PBM Contract Terms Every Benefits Professional Should Know

The Transparent PBM Model

In response to growing employer frustration with traditional PBM opacity, a new category of "transparent" or "fiduciary" PBMs has emerged. These models — offered by companies like Capital Rx, Navitus, and SmithRx — commit to pass-through pricing, full rebate transparency, and no spread pricing. Some even operate as fiduciaries, meaning they are legally obligated to act in the plan sponsor's best interest.

For self-funded employers with 500+ covered lives, the transparent PBM model deserves serious evaluation. The cost savings can be substantial — typically 15–30% vs. traditional PBM arrangements — though implementation requires careful planning and robust pharmacy benefit expertise on the employer side.

Specialty Drug Management: The $1M Member Problem

Specialty drugs — biologics, gene therapies, and increasingly GLP-1 medications like Ozempic and Wegovy — represent the single biggest cost driver in employer pharmacy benefits. A single high-cost claimant on a specialty medication can cost a self-funded plan $1 million or more annually.

Managing specialty drug costs requires a multi-pronged strategy:

• Site-of-care optimization (shift from hospital outpatient to physician office or specialty pharmacy)
• Specialty carve-out (separate specialty pharmacy management from medical PBM)
• Copay accumulator and maximizer programs (managing manufacturer coupon impact)
• Clinical prior authorization with evidence-based criteria
• International sourcing for select high-cost medications (where legally permissible)
• GLP-1 management programs with lifestyle intervention requirements

Getting Certified in Pharmacy Benefits

For benefits professionals who want to develop professional-grade expertise in PBM management, the CPBS (Certified Pharmacy Benefits Specialist) from ACoBS is the only certification in the U.S. specifically focused on pharmacy benefits management and accredited by ACPE, SHRM, and HRCI.

The CPBS curriculum covers PBM contract analysis and auditing, formulary and rebate management, specialty drug strategy, and transparent benefit design — exactly the skills needed to manage the modern pharmacy benefit with confidence.